Recruiting Trials

Tuberculosis

TB045 – A BCG Challenge Study to Evaluate the Efficacy of a new TB Vaccine

TB045 – A BCG challenge study in healthy adults to evaluate the efficacy of a new TB vaccine. If you are 18 to 55 years old, in good health, and know that you have had a BCG vaccine before or know that you have never had the BCG vaccine before, you may be eligible to participate.

The study involves a maximum of 14 visits over a period of around up to 6 months. Participants will be reimbursed for their time and travel up to £1465.

For more information please use the following link.

COVHIC003 – SARS-CoV-2 Human Challenge Study

We’re learning how the body responds to SARS-CoV-2.

If you’re aged 18–50 and in good health, you may be eligible to take part in this research study, which includes pre-screening, screening, quarantine, and 4 follow-up visits.

💰 Paid up to £3,935
📍 Locations: Experimental Medicine Clinical Research Facility (EMCRF), University of Oxford

📩 challenge@paediatrics.ox.ac.uk. 

🔗 For more information please use the following

Would you like to keep up to date with trials?